Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 3Withdrawn 1Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Observational 4Interventional 3

Sponsor

Cancer Type

Genitourinary 7Gastrointestinal 2Thoracic 1Gynecologic 1CNS 1Breast 1

Conditions

Neoplasms 14Lung Neoplasms 10Breast Neoplasms 9Colorectal Neoplasms 8Prostatic Neoplasms 7Stomach Neoplasms 3Rectal Neoplasms 3Polycystic Ovary Syndrome 3Neoplasm Metastasis 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Smoking Cessation 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic cancer, adult 2Ovarian Neoplasms 2Neoplastic Cells, Circulating 2Motor Activity 2Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia 2Endometrial Neoplasms 2Wilms Tumor 1Venous Thromboembolism 1Vaginal Neoplasms 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1Testicular Germ Cell Tumor 1Stroke 1

Interventions

Docetaxel 292Prednisone 240enzalutamide 193Leuprolide 185Radiotherapy 179Abiraterone Acetate 169Magnetic Resonance Spectroscopy 163bicalutamide 141Goserelin 138Androgen Antagonists 121acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 108Radiosurgery 108apalutamide 92gallium 68 PSMA-11 81abiraterone 81Specimen Handling 73darolutamide 65Surveys and Questionnaires 64Gonadotropin-Releasing Hormone 63Triptorelin Pamoate 58Radiation 57Biopsy 57Brachytherapy 54cabazitaxel 52Standard of Care 51Radiotherapy, Intensity-Modulated 51Zoledronic Acid 50pembrolizumab 49luprolide acetate gel depot 49Flutamide 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Hematologic Tests × Clear all
NCT03568188 2026-02-24

FOCALE

Hospices Civils de Lyon

Phase 2 Completed
174 enrolled
Genitourinary

Prostatic Neoplasms

NCT06717295 2026-01-02

CCANED-CIPHER

Dysplasia Diagnostics Limited

Recruiting
6,000 enrolled
CNSGastrointestinalGenitourinaryGynecologicThoracic

Pancreatic cancer, adult, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT03284684 2025-12-01

Periop ctDNA

Centre Hospitalier Universitaire de Nīmes

Completed
30 enrolled
BreastGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Prostatic Neoplasms

NCT02346526 2022-09-29

A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer

Massachusetts General Hospital

Phase 2 Completed
22 enrolled 14 charts
Genitourinary

Prostatic Neoplasms

NCT02747563 2016-04-21

Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination

Kaplan Medical Center

Phase 1 Unknown
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT00523471 2016-02-26

Blood Test to Measure DNA Damage in Blood

AHS Cancer Control Alberta

Terminated
40 enrolled
Genitourinary

Prostatic Neoplasms

NCT01838265 2014-12-08

MGM

University of Miami

Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡